Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Am J Transplant. 2013 Feb 15;13(3):676–684. doi: 10.1111/ajt.12044

Table 3.

Proportion of subjects with abnormal Levels of Urine Proteins at 1-year and Allograft Histology N (%)

Protein
(>50mg/g)
Protein
(>200mg/g)
Albumin IgG IgM α1m RBP
Histopathologic Grouping
All Patients (N= 221) 176 (79) 44 (20) 101 (46) 96 (43) 170 (77) 126 (57) 119 (54)
Normal (N= 84) 67 (80) 11 (13) 32 (38) 32 (38) 59 (70) 45 (54) 39 (46)
IFTA (N= 79) 63 (79) 16 (20) 37 (47) 38 (48) 61 (77) 48 (61) 47 (60)
Inflammation (N= 14) 12 (86) 6 (43) 10 (71) 8 (57) 14 (100) 10 (71) 9 (64)
GN (N= 33) 24 (73) 10 (30) 18 (55) 15 (46) 29 (88) 20 (61) 19 (58)
Vascular (N= 11) 10 (91) 1 (9) 4 (36) 3 (27) 7 (64) 3 (27) 5 (46)
Histological Risk Grouping
All Patients (N= 216) 172 (80) 41 (19) 98 (45) 93 (43) 165 (76) 122 (57) 116 (54)
Normal (N= 90) 72 (80) 11 (12) 34 (38) 33 (37) 63 (70) 46 (51) 41 (46)
IFTA (N= 72) 57 (79) 14 (19) 33 (46) 33 (46) 53 (74) 42 (58) 41 (57)
IFTA + i (N= 21) 19 (91) 6 (29) 13 (62) 12 (57) 20 (95) 14 (67) 15 (71)
GN (N= 33) 9 (27) 10 (30) 18 (55) 15 (46) 29 (88) 20 (61) 19 (58)

IFTA is Interstitial Fibrosis and Tubular Atrophy, GN is Glomerular